Abstract
Patients with resectable colorectal hepatic metastases are increasingly being treated with preoperative systemic chemotherapy. Recent studies have delineated regimen-specific toxicities and their impact on patient outcomes after hepatic resection. This review discusses selected important research findings on the risks of pre-operative chemotherapy for resectable colorectal liver metastases, focusing specifically on hepatotoxicity.
Original language | English (US) |
---|---|
Pages (from-to) | 87-92 |
Number of pages | 6 |
Journal | Current Colorectal Cancer Reports |
Volume | 4 |
Issue number | 2 |
DOIs | |
State | Published - Apr 2008 |
ASJC Scopus subject areas
- Hepatology
- Oncology
- Gastroenterology